/

regenxbio

Develops adeno-associated virus gene therapies for rare and chronic diseases.

BiotechnologyPharmaceuticals regenxbio.com ↗

Company facts

Founded: 2008
Employees: 394
Headquarters: United States
Type: Public
Listed: NASDAQ: RGNX